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Help seeking and suicidality 
among people with epilepsy in a rural low 
income country setting: cross-sectional survey
Ruth Tsigebrhan1*, Charlotte Hanlon1,2, Girmay Medhin3 and Abebaw Fekadu1,4
Abstract 
Backgrounds: Epilepsy is a serious neurological disorder associated with a high level of psychiatric comorbidity. Sui-
cidality is a recognised complication of epilepsy. As part of developing an integrated service for people with epilepsy 
(PWE) and priority psychiatric disorders within primary care, a cross-sectional study was conducted in a rural district 
in Ethiopia to investigate patterns of help-seeking, suicidality and the association with duration of untreated epilepsy 
(DUE) among PWE.
Methods: Cases were identified through community key informants and diagnosis was confirmed by trained 
primary care clinicians. Severity of epilepsy, depression and suicidality were assessed using standardised methods. 
Multivariable regression analysis was used to test the hypothesis that suicidality was associated with DUE.
Results: The majority of PWE sought help from both religious and biomedical healing centres. The lifetime treatment 
gap for biomedical care was 26.9%, with a 12 month treatment gap of 56.7%. Close to one-third (29.9%) of partici-
pants reported using traditional and cultural healing practices. Nearly one-third (30.2%) of participants reported sui-
cidality (suicidal ideation, plan or attempt) in the previous 1 year. The median (IQR) DUE was 24 months (4–72). There 
was no association between DUE and suicidality. In the multivariable model, being married [odds ratio (OR) 2.81, 95% 
CI 1.22, 6.46], increased depressive symptoms (OR 1.17, 95% CI 1.10, 1.26) and perceived poorer wealth relative to oth-
ers (OR 2.67, 95% CI 1.07, 6.68) were associated independently with suicidality.
Conclusion: In this study, PWE sought help from both biomedical and religious healing centres. Suicidality and 
depression have a high prevalence in PWE in this setting. Integrated mental and neurological health care within pri-
mary care is needed for improved holistic management of epilepsy.
Keywords: Suicidality, Help seeking, Untreated epilepsy, Depression, Low income country
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Background
Epilepsy can be a chronic and disabling disorder which 
has an impact on social, interpersonal and occupational 
functioning [1]. Globally, an estimated 65 million people 
are affected by epilepsy [2]. In low- and middle-income 
countries (LMICs), the median estimate for lifetime prev-
alence of epilepsy is 15.4 per 1000 people in rural areas 
and 10.3 per 1000 in urban settings [3]. Epilepsy is esti-
mated to have resulted in 116 deaths per 100,000 people 
worldwide in 2013 [4]. In Ethiopia, the prevalence of epi-
lepsy was 520/100,000 people in a large-scale, rural, com-
munity-based survey [5].
Studies from high- and middle-income countries indi-
cate an increased risk of psychiatric comorbidity among 
people with epilepsy compared to the general population 
[2, 6]. Hospital based studies conducted in Ethiopia have 
shown that the prevalence of depression is high among 
people with epilepsy [7–9]. Comorbid psychiatric dis-
orders, such as depression, have a substantial negative 
impact on quality of life [10–12] and are important risk 
factors for suicidal behaviours [13]. In large case control 
studies from Sweden and Denmark, the odds of suicide 
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were increased up to threefold in people with epilepsy 
compared to the general population [14, 15].
In LMICs, the proportion of people receiving basic 
treatment for epilepsy is limited [3, 16]. In a general 
population and hospital-based survey conducted in 12 
African countries, a lifetime treatment gap of 30.6% was 
identified, with 11.7% of the respondents using traditional 
healing exclusively [17]. In a rural African community, 
the mean duration of epilepsy before receiving evidence-
based biomedical treatment was six and half years [18]. 
The simultaneous use of biomedical and traditional treat-
ments for epilepsy has been found to be commonplace 
[19, 20]. A reliance upon traditional healing approaches 
has also been observed in Ethiopia [21]. In some situa-
tions traditional and religious treatment modalities may 
be the only choice available, with an absence of accessible 
biomedical services for people with epilepsy [22].
There have been few studies from low-income coun-
try contexts to investigate the help-seeking behaviour 
of people with epilepsy (PWE) in relation to suicidal-
ity. Undetected and untreated epilepsy is expected to be 
associated with higher psychiatric morbidity and elevated 
suicidality. Evidence is needed to inform current plans to 
scale up the integrated management of people with men-
tal and neurological disorders in LMICs and to reduce 
the delay in people accessing treatment.
The aim of this study was to estimate the time delay 
between first seizure and initial receipt of evidence-based 
treatment (duration of untreated epilepsy) and to explore 
the association with suicidality (suicidal idea, plan or 
attempt). We hypothesized that suicidality in people with 
epilepsy would be associated with longer duration of 
untreated epilepsy.
Methods
Design
Cross-sectional survey of community-ascertained cases 
of PWE attending a newly implemented primary care-
based epilepsy service.
Setting
The study was carried out as part of the programme for 
improving mental health care (PRIME), a research pro-
gramme consortium across five LMICs (Ethiopia, Nepal, 
India, South Africa and Uganda) [23]. PRIME Ethiopia 
is currently implementing a programme of care for peo-
ple with epilepsy, psychosis, bipolar disorder, depression 
and alcohol use disorders integrated into primary health 
care in the Sodo district of Ethiopia [24]. Sodo district is 
located in the Gurage Zone, 100  km south of the capi-
tal city, Addis Ababa, with a population of 161,952 peo-
ple at the time of the 2013 census [25]. The district is 
predominantly rural and is classified administratively into 
58 sub-districts (kebeles), the lowest government admin-
istrative structure. Amharic is the official language of 
the Sodo district. There are a total of eight primary care 
health centres and 54 health posts (community based 
health facilities) available in the district. However, at the 
time of the study, there was no formal mental health or 
neurological care provided within the district. The near-
est service was the nurse-led psychiatric unit in Butajira 
hospital and a neurological clinic (“Grarbet”) which is 
30 km away from the centre of Sodo district [25, 26].
Study population and sampling
Data were collected from adults who had been identified 
as having possible epilepsy by trained community key 
informants, referred to primary care and then confirmed 
to have convulsive epilepsy by a primary health care cli-
nician. This key informant method was previously found 
to be effective for psychosis case ascertainment in the 
neighboring district [27]. Primary care-based treatment 
was offered according to the evidence-based treatment 
guidelines of the World Health Organisation’s men-
tal health Gap Action Programme Intervention Guide 
(WHO mhGAP-IG) [28]. The inclusion criteria were 
(1) age ≥18 years, (2) mhGAP definition of a convulsive 
seizure: “recurrent (at least twice) unprovoked seizure 
occurring days or weeks apart”. and (3) resident in Sodo 
district. The assessment recommended by mhGAP-IG 
includes neurological examination but does not require 
an  electroencephalogram (EEG).  The first thirty cases 
(10%) were assessed by a neurologist for confirmation of 
the diagnosis. There was 100% concordance between the 
epilepsy diagnosis made by the primary health care clini-
cians and that made by the neurologist.
The target sample size of 300 people was determined 
for the PRIME intervention study [29]. The sample size 
was adequate to detect a 6  month difference in DUE 
between those with and without suicidality with the fol-
lowing assumptions: DUE among those with suicidality 
is 70  months and those without is 64  months, standard 
deviation of 15, 90% power, 95% confidence and 10% 
contingency.
Measurements
Primary outcome: suicidality
Suicidality was defined as the presence of one of the 
following: suicidal ideation or suicidal plan or suicide 
attempt in the past 12 months. Suicidality was measured 
using the suicide module of the composite international 
diagnostic interview (CIDI) [30]. The acceptability, reli-
ability and feasibility of the Amharic version of CIDI was 
evaluated in the Ethiopian setting previously [31].
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Primary exposure: duration of untreated epilepsy (DUE)
DUE was defined as the time between the first seizure and 
the first receipt of evidence-based treatment (in months) 
measured by participant self-report. Evidence-based treat-
ment was defined according to WHO’s mhGAP-IG [28].
Potential confounding variables
  • Socio-demographic characteristics: age, sex, educa-
tion, marital status, relative wealth, area of residence.
  • Types of seizure disorder [focal seizures (FS) and 
generalized tonic–clonic (GTC)] as diagnosed by the 
primary health care clinician.
  • Severity of epilepsy: measured using the national 
hospital severity scale (NHS3) which is an eight 
item questionnaire to evaluate the nature and con-
sequences of seizures during the preceding 6 months 
[32]. The higher the score the greater the severity of 
epilepsy. Collateral information was obtained from 
attendants where possible.
  • Help seeking patterns were measured by asking 
whether the person had sought treatment from any 
healing places for their seizure and the type of treat-
ment they had used. The types of traditional and reli-
gious treatments used in the setting are diverse [33]. 
The help sought was categorized as traditional, reli-
gious, biomedical or no treatment at all.
  • Accessibility of care, measured in terms of the average 
time to reach the nearest health centre (in minutes).
  • Alcohol use disorders was measured using the Alco-
hol Use Disorder Identification Test (AUDIT) [34]. 
The AUDIT has been adapted for Ethiopia [35], 
with support for the recommended cut off scores for 
hazardous use (≥8), harmful use (≥16 points) and 
dependent drinking (≥20 points).
Depression was hypothesized to be on the causal path-
way (a potential mediator) between DUE and suicidal-
ity. Depressive symptoms were measured using the total 
score on the patient health questionnaire (PHQ-9).
The PHQ-9 is based on the DSM-IV diagnostic crite-
ria for major depressive disorder and has been used to 
screen adults (not including PWE) for depression with 
an optimal cut off score 10 in clinical and community 
settings [36]. Categories of PHQ score have been used 
to define levels of depression [37]: no depression for a 
PHQ-9 score of 0, mild depression for PHQ score from 
1 to 9, moderate depression for PHQ score from 10 to 
14 and severe depression for a score of 15 or above. The 
Amharic version of the PHQ-9 has been validated in pri-
mary care settings in rural Ethiopia, with a score of five 
or more optimal for indicating risk of depression among 
adults without epilepsy [38]. As the PHQ-9 has not been 
validated in PWE in Ethiopia we used both cut-offs.
Family size was considered to be an indicator of social 
support and conceptualised as a potential effect modifier 
of the association between DUE and suicidality.
Data collection
All lay interviewer-administered measures were trans-
lated into the local language (Amharic). The lay data 
collectors were trained on the administration of the 
instruments for 1 week by psychiatric nurses and PRIME 
research assistants (Master’s level). Training included 
role play and observed interviews with volunteers. The 
confirmatory clinical evaluation of epilepsy and the epi-
lepsy severity scale, both of which are observer-rated 
scales, were completed in English by primary health care 
clinicians. Close supervision was provided by the project 
employees and psychiatric nurses.
Data analysis
Data were double entered using Epi-data version 3.1 and 
analysed using STATA version 12. Simple descriptive 
analyses were used to summarise the socio-demographic 
and clinical characteristics of the study participants. Help 
seeking patterns and type of treatments used by the study 
participants were calculated as percentages and their asso-
ciation with suicidality was assessed using Pearson Chi 
square or Fisher’s exact test as appropriate. The median 
DUE was calculated by including the people who had 
sought previous evidence-based medical treatment com-
bined with those people who accessed their first biomedi-
cal treatment through PRIME. Hypothesis driven analysis 
of the association between DUE and suicidality was car-
ried out using multiple logistic regression modelling, 
adjusting for confounders identified a priori. Multivariable 
logistic regression was conducted, including only the vari-
ables which were associated with suicidality (at the level 
of p < 0.2) in the univariate analysis. A sensitivity analysis 
was also conducted with the suicide item removed from 
the PHQ-9 total score. Exploration of a mediational role 
of depressive symptoms was planned by adding the PHQ 
score into the multivariable model. Exploration of effect 
modification by family size was also done.
Result
A total of 298 people with epilepsy were assessed. All of 
the participants with probable epilepsy who had been 
detected and referred from the community attended 
the designated health centre. As shown in Table  1, the 
majority were male (58.7%) and had no formal educa-
tion (60.3%). Around one-third were less than 25  years 
of age (34.0%) with a mean age of 33.3 years (SD = 13.7). 
Almost all participants (90.6%) were living in rural areas 
but residing within two hours travel of their nearest 
health centre. Nearly two-thirds of participants perceived 
Page 4 of 9Tsigebrhan et al. Int J Ment Health Syst  (2017) 11:44 
their socioeconomic status to be low or very low rela-
tive to others (65.0%). Family size ranged from one up to 
twelve members, with an average of three children per 
household (Table 1).
Epilepsy diagnosis, severity and duration of untreated 
illness
Almost all (93.0%) of the participants were diagnosed 
with generalized tonic–clonic seizures (GTC) (Table  2). 
The mean epilepsy severity scores for GTC and FS were 
not meaningfully different. The age of onset of sei-
zures ranged from less than 1 year up to a maximum of 
70  years, with a median age of onset of 17  years (IQR 
10–29). The median total duration of illness was 10 years 
(IQR 4–18.5). The lifetime treatment gap was 26.9% and 
the 12 month treatment gap was 56.7%. The median DUE 
was 24 months (IQR 4–72) (Table 2).
Suicidality and psychosocial characteristics
One-third of the study participants (30.2%) reported sui-
cidal ideation during the preceding 12 months, 15.8% had 
a suicide plan and 9.4% had attempted suicide.
The prevalence of possible depression was 70.8% using 
the cut-off of 5 or more, and 34.9% using the cut-off of 
10 or more. Over a quarter of participants had prob-
able alcohol use disorder (27.2%). The median DUE was 
24  months for both participants with suicidality (IQR 
8–84) and non-suicidality (IQR 3.5–72).
Help‑seeking for epilepsy
All participants who reported seeking help from non-
biomedical or biomedical sources attended one or more 
religious settings (churches, monasteries, mosques and 
holy water places). Help seeking patterns are described 
in supplementary table one. Nearly one-third (29.9%) of 
participants reported using traditional and cultural heal-
ing practices. Help-seeking from churches was higher in 
people expressing suicidality compared to those without 
(51.1% vs. 31.3%;  X2 10.6, df = 1, p = 0.001) and similarly 
for those attending monasteries (22.2% vs. 11.5%;  X2 5.70, 
df = 1, p = 0.02). There was no significant difference in 
the mean epilepsy severity score of those participants 
with GTC and attending churches compared to those 
who did not (p = 0.80) or between those attending mon-
asteries compared to non-attenders (p = 0.98).
Duration of untreated epilepsy and suicidality
There was no significant association between DUE and 
suicidality in univariate analysis [odds ratio (OR) 0.85, 
95% confidence interval (CI) 0.50, 1.44] or after adjusting 
Table 1 Socio-demographic characteristics
* Includes students, pensioners and volunteer workers
** Others include Mareko, Meskana, Kebena
Characteristics (total N = 298) Number (%)
Age (years)
 <25 101 (34.0)
 25–34 71 (23.9)
 35–44 62 (20.9)
 ≥45 63 (21.2)
Mean age (standard deviation; SD) 33.3 (13.7)
Gender
 Male 175 (58.7)
 Female 123 (41.3)
Education
 No formal education 178 (60.3)
 Formal education 118 (39.7)
Employment
 Employed 37 (12.5)
 Unemployed 55 (18.6)
 Farmer 102 (34.6)
 House wife 57 (19.3)
 Others* 45 (15.2)
Area of residence
 Rural 270 (90.6)
 Urban 28 (9.4)
Perceived relative wealth
 Very low 50 (16.8)
 Low 143 (48.2)
 Average and above 104 (35.0)
Marital status
 Single 138 (46.3)
 Married 129 (43.3)
 Formerly married 31 (10.4)
Religion
 Orthodox christian 275 (92.2)
 Protestant 13 (4.4)
 Muslim 7 (2.4)
 Others 3 (1.0)
Ethnicity
 Gurage 278 (93.3)
 Oromo 17 (5.7)
 Amhara 2 (0.7)
 Others** 1 (0.3)
Mean family size (SD) 5.5 (2.1)
Mean number of children (SD) 3.2 (2.4)
Duration of travel to reach the nearest health center (min)
 0–30 120 (40.8)
 31–120 141 (48.0)
 >120 33 (11.2)
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for hypothesised confounders (OR 3.38, 95% CI 0.59, 
19.34). Even if there was a change of odds ratio of DUE in 
the multiple logistic regression after using the interaction 
term, this was not significant. In view of this finding, no 
test for mediation by depression was conducted.
Multivariable analysis of factors associated with suicidality
The adjusted odds of suicidality among PWE were statis-
tically significantly higher among people who were mar-
ried (OR 2.81, 95% CI 1.22, 6.46), had higher levels of 
depressive symptoms (OR 1.17 for each 1 point increase 
in PHQ-9 score, 95% CI 1.10, 1.26) and those with per-
ceived very low relative wealth (OR 2.67, 95% CI 1.07, 
6.68) in the final multivariable model (Table  3). In the 
sensitivity analysis, the association of suicidality with 
depression was unchanged after the suicide item was 
removed from the PHQ-9 questionnaire (adjusted OR 
1.16 for each 1 point increase in PHQ-9 score, 95% CI 
1.09, 1.23). Even though family size was hypothesized to 
be an effect modifier, the interaction between DUE and 
family size was non-significant (p = 0.10) (Table 3).
Discussion
In this cross-sectional study of community-ascertained 
PWE about to receive primary care-based treatment 
in rural Ethiopia, suicidality was present in nearly one-
third of PWE, and was associated independently with 
increased depressive symptoms, being married and hav-
ing low socio-economic status. The 12 month treatment 
gap for epilepsy was high (56.7%) and the median dura-
tion of untreated epilepsy was long (24  months). The 
findings of this study did not support the hypothesis that 
longer DUE was associated with increased suicidality.
The high prevalence of suicidality in PWE in our study 
is in keeping with findings from studies conducted in high 
income countries [14, 15, 39]. The prevalence of suicidality 
in PWE in this study was also higher than the prevalence 
in the general population in Sodo district (20.5%) [40]. A 
previous suicide attempt is one of the major risk factors 
for future completed suicide and, as such, is an important 
target for suicide prevention efforts [39]. Nearly one in 
ten PWE in our study had attempted suicide in the pre-
ceding 12 months. This result underlines the importance 
of assessment for suicide risk in PWE and interventions 
to reduce risk. The high levels of stigmatising attitudes 
towards both epilepsy and mental health problems may 
complicate early recognition of suicide risk and inter-
ventions to prevent suicide in this rural community [26, 
41, 42]. In a previous study conducted in a rural district 
neighbouring the setting for the current study, only 21.5% 
of key informants considered mental illness to be possible 
cause of suicide [43]. Once a person has attempted sui-
cide, this brings further stigma due to prohibitions against 
suicide an all of the major faiths in Ethiopia [43].
In agreement with research from other non-African 
countries we found an association between both depres-
sion [15, 39, 44] and low socioeconomic status [45] 
with suicidality. Furthermore, depression was found to 
be associated with suicidality independently of seizure 
severity [13]. The prevalence of depression among PWE 
in this resource limited setting using the primary care 
validated cut-off (70.8%) was also higher than the gen-
eral population depression prevalence (28.8%) using the 
same validated cut-off (5 or more) [38]. This prevalence 
of depression was also higher than the prevalence that 
is reported in the institution based studies from Ethio-
pia [7–9]. Various explanations have been proposed to 
explain the elevated levels of depression in epilepsy; (1) 
underlying structural brain disease, (2) damage related 
to uncontrolled seizures, and (3) psychosocial impact 
of the stigma and disability associated with epilepsy [6]. 
Validated cut-off scores to indicate possible depression in 
Table 2 Clinical characteristics of  people with  epilepsy 
attending primary care (N = 298)
IQR inter quartile range, AUDIT Alcohol Use Disorder Identification Test, NHS3 
national hospital severity scale, SD standard deviation PHQ-9 patient health 
questionnaire, DUE duration of untreated epilepsy
* Categories defined by PHQ scores as described in the methods
Clinical variable Response categories Number (%)
Types of epilepsy Focal seizure 21 (7.0)
Generalized tonic–clonic 277 (93.0)
Median age of onset (IQR) 17.0 (10–29)
Median duration of illness 
(IQR)
10 (4–18.5)
Epilepsy severity score 
[mean NHS3 score (SD)]
Focal seizure 10.0 (4.6)
Generalised tonic–clonic 
seizure
10.6 (3.5)
Suicidality Suicidal ideation 90 (30.2)
Suicidal plan 47 (15.8)
Suicidal attempt 28 (9.4)
Depressive symptoms* No depression 13 (4.4)
Mild depression 181 (60.7)
Moderate depression 80 (26.8)
Severe depression 24 (8.1)
Alcohol use disorder No alcohol use 217 (72.8)
Hazardous 48 (16.1)
Harmful 8 (2.7)
Dependent 25 (8.4)
Median DUE (IQR) 24 (4–72)
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primary care populations in general (mostly with acute 
infectious conditions) may not be valid in persons with 
chronic disorders. However, even with a more conserva-
tive cut-off score (10 or more), more than one-third of 
PWE had high levels of depressive symptoms. These 
high levels of depression could also be related to the high 
prevalence of alcohol use in this population. In previous 
studies, co-morbid depression in PWE has been demon-
strated to have a substantial negative impact on quality 
of life [10, 13] and contributes to greater disability than 
attributed to seizures [12] and to increased risk of suicide 
[15, 45].
Table 3 Factors associated with 12 months suicidality (dependent variable) in people with epilepsy (n = 298)
AUDIT Alcohol Use Disorder Identification Test, NHS3 national hospital severity scale, PHQ-9 patient health questionnaire, DUE duration of untreated epilepsy, GTC 
generalized tonic seizure, FS focal seizure, HC health centre
Characteristic  
(independent variables)
Suicidality  
number (%)
Univariate analysis Multivariable analysis
Crude odds ratio  
(OR) for suicidality
95% Confidence  
interval (CI)
Adjusted OR  
for suicidality
95% CI
Age (in years) 1.01 0.99, 1.02 0.99 0.95, 1.02
Gender
 Male 44 (14.7) 1.00 1.00
 Female 46 (15.4) 1.78 1.08, 2.93 1.61 0.87, 2.98
Marital status
 Single 33 (11.1) 1.00 1
 Married 46 (15.4) 1.76 1.04, 3.00 2.75 1.19, 6.35
 Formerly married 11 (3.6) 1.75 0.76, 4.02 1.56 0.46, 5.26
Relative wealth
 Average and above 21 (7) 1.00 1.00
 Poor 49 (16.4) 2.04 1.14, 3.72 1.64 0.80, 3.33
 Very poor 19 (6.4) 2.42 1.15, 5.10 2.67 1.07, 6.68
Education
 No formal 56 (18.8) 1.00
 Formal education 34 (11.4) 0.89 0.53, 1.48
Area of residence
 Urban 9 (3) 1.00
 Rural 81 (27.2) 0.90 0.39, 2.08
Family size 0.94 0.83, 1.06 1.03 0.84, 1.27
Duration of travel to reach the nearby health center (minutes)
 0–30 33 (11.1) 1.00
 31–120 43 (14.4) 1.16 0.68, 1.98 0.89 0.47, 1.72
 >120 13 (4.4) 1.71 0.77, 3.83 1.16 0.42, 3.15
DUE (in months)
 0–23.99 38 (12.8) 1.00 1.00
 24–636 40 (13.4) 0.85 0.50, 1.44 3.24 0.56, 18.86
Biomedical treatment
 Yes 68 (22.8) 1.00
 No 22 (7.4) 1.20 0.68, 2.11
Epilepsy severity (total NHS3 score)
 FS 1.09 0.99, 1.19
 GTC 1.03 0.97, 1.12
Depressive symptoms (total 
PHQ-9 score)
1.18 1.11, 1.25 1.17 1.10, 1.26
Use of alcohol
 No use 64 (21.5) 1.00
 Hazardous 17 (5.7) 1.31 0.68, 2.54
 Harmful 2 (0.7) 0.80 0.16, 4.05
 Dependent 7 (2.3) 0.93 0.37, 2.33
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The association of suicidality with being married is 
inconsistent with other studies [45] but this unusual 
association has been also observed in the general popu-
lation of Sodo district [40]. The possible explanation for 
this association has been proposed as increased conflict 
in married couples [40]. In general, people with epilepsy 
in our study were less likely to be married (only 50%) 
compared to the general population (74.8%) [40]. It is 
likely that the low prevalence of marriage is related to 
stigma, poor seizure control and misunderstanding of the 
cause of epilepsy. It is also possible that in people with 
epilepsy who do get married (or who develop epilepsy 
after marriage) there may be more direct exposure to 
stigmatising attitudes and discrimination from the fam-
ily of the spouse, which could explain the higher levels of 
suicidality and the rates of discrimination and disability 
related to epilepsy could be much worse for those who 
are married than the singles. This hypothesis needs fur-
ther exploration of the perception of married PWE on 
stigma and discrimination in this rural setting.
The overall prevalence of alcohol use disorders (27.2%) 
was high in this community sample of people with epi-
lepsy and it was even higher than the general Sodo dis-
trict population prevalence (22.6%) [40]. Alcohol use 
disorders have a causal role in the development of epi-
lepsy which may explain the elevated levels of alcohol 
use disorders; however, the stigma and elevated mental 
health problems associated with epilepsy may also lead 
to increased risk of substance use. A prospective study 
is needed to investigate the direction of association. The 
lack of association between AUDs and suicidality was 
unexpected.
Although the median DUE was 2 years, it was lower (by 
2 years) than that found in a study conducted in north-
ern Ethiopia 16 years ago [22]. The average DUE in this 
study was also lower than the findings from another Afri-
can low income country (6.5  years) [18]. This apparent 
decline in DUE over time could be due to the availabil-
ity of a neurological clinic (‘Grarbet’) in the neighbouring 
town, although over half of PWE still had not accessed 
evidence-based treatment in the preceding year [26]. This 
suggests that many participants who had initiated evi-
dence-based treatment are likely to have had subsequent 
prolonged periods of non-treatment, leading to under-
estimation of the impacts of delayed biomedical treat-
ment on suicidality. The wide confidence interval and the 
lack of association between DUE and suicidality would 
have been also minimized with bigger sample size. Fur-
thermore, the measurement of self-reported DUE could 
have been affected by recall bias, which might have been 
expected to bias the finding to the null.
The treatment gap identified for epilepsy in this rural 
district of Ethiopia is comparable to the result of a 
multi-country African study [17], but lower than the 
findings in studies from Ethiopia [46] and other low 
income countries [16, 19, 47]. A number of possible 
causes of treatment gap have been found in the Sub-
Saharan African countries including inconsistent avail-
ability and unaffordability of anti-epileptic medications, 
stigma, inadequate skilled health professionals, limited 
access to health institution, medication side effects and 
toxicity [16, 47].
A study from Ethiopia found a high percentage (12%) 
of default from epilepsy treatment because of the pref-
erence for traditional remedies [21]. Therefore, besides 
the need to expand local access to low cost anti-epileptic 
drugs, belief systems about the causes of epilepsy, comor-
bid psychiatric disorders and the acceptability of bio-
medical treatments may be important in understanding 
the factors playing in treatment adherence. This study 
has also demonstrated the presence of widespread use 
of religious treatment facilities among the study partici-
pants who are treated with or without the addition of evi-
dence based medicine, in keeping with other studies [17, 
20]. The attribution of causes of epilepsy to supernatural 
forces might have also influenced the preference for reli-
gious help seeking in participants [33]. Providing mental 
health education and integrating traditional healers of 
the rural communities of Ethiopia into the contemporary 
biomedical treatment could facilitate the referral system 
to medical centres and narrow the treatment gap.
Integration of mental health services at the primary 
health care level is likely to further enhance detection 
and management of co-morbid mental health problems 
in PWE. Our findings indicate that PWE may benefit 
from the co-ordinated scale-up of integrated services for 
mental health and neurological conditions, due to the 
high levels of co-morbid depression and suicidality. The 
World Health Organisation’s mhGAP trains primary care 
workers in evidence-based guidelines for suicide, depres-
sion and epilepsy. However, the reliance on psychotropic 
medication to treat depression in this setting may not 
be acceptable to PWE who are already taking long-term 
medications [24]. There is a need to adapt and expand the 
availability of psychosocial interventions for depression 
in PWE, combined with poverty reduction programs to 
address the social determinants of mental health prob-
lems in this setting.
The inclusion of community-ascertained cases, using 
rigorous methodology which has been used in this rural 
Ethiopian context previously, is a strength of this study 
[27]. The pragmatic design with very few exclusion cri-
teria ensured representativeness of the sample and gen-
eralisability to other rural areas of Ethiopia, Standardised 
and validated measures were used which had robust psy-
chometric properties. The primary hypothesis could only 
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have been examined with a cross-sectional analysis due 
to the ethical imperative to provide treatment to people 
identified as having epilepsy. Even though the majority 
of measurements relied upon self-report questionnaires, 
information bias (recall bias) was minimized by also 
interviewing the attendants of the participants.
The main limitation of the study was the cross-sectional 
design. Therefore, it was not possible to investigate cau-
sality or the temporal relationship between untreated epi-
lepsy and suicidality, or the temporal relationship between 
religious healing and suicidality. A prospective study and 
qualitative exploration of the individual’s perspectives on 
religious healing are needed. In addition to the clinical 
diagnosis, standardised approaches to diagnosing epilpsy 
could have increased the validity of the study. Although 
we included a wide range of potential confounders in the 
hypothesis testing multivariable analysis looking at dura-
tion of untreated epilepsy and suicidality, other important 
factors (e.g. presence of other psychiatric disorders such 
as anxiety and psychosis) may have been relevant. There 
is also potential limitation in this study for not analysing 
sub-categories of suicidality. The nature of the sampling 
procedure and our sample size may have limited our 
power to detect true associations. The finding from this 
paper may not be applicable to the urban parts of Ethiopia 
since the socio-demographic and health related factors 
are different from the rural area.
Conclusions
In this study of PWE in a rural Ethiopian community, the 
prevalence of suicidality was high and associated strongly 
with depressive symptoms. Integrated management of 
epilepsy and associated mental health conditions at the 
primary care level, as recommended by the WHO, has 
the potential to improve the holistic treatment, reduce 
suicide risk and enhance the quality of life of PWE. How-
ever, reducing the epilepsy treatment gap requires atten-
tion to preferred help-seeking practices in this rural, 
non-Western society.
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